web analytics

Editorial Policy

Stem Cell Tracker covers stem cell science in plain language: what’s proven, what’s promising, and what’s still hype.

Who we are

Stem Cell Tracker is independently owned and edited by Ty Lancaster. We don’t sell treatments, and we don’t take payment for coverage.

How we choose stories

Each weekday we pick the most significant stem cell news, mostly peer-reviewed studies, clinical trial results, regulatory decisions, and major institutional announcements.

Sourcing

Every article links its original source, and the underlying study whenever one exists. We always say how far the research has gotten, whether it’s a lab dish, an animal study, an early human trial, or an approved therapy.

How we use AI

AI tools help us research, draft, and create images. Ty Lancaster reviews every article for accuracy, sourcing, and tone. Featured images are original illustrations, not photos of real patients or labs.

Health information

Our articles are for education only and aren’t medical advice. We don’t endorse clinics or unapproved treatments. If you’re considering a stem cell therapy, talk to your doctor, and check our clinic red-flags checklist first.

Corrections

If we get something wrong, we fix it quickly and add a dated note at the bottom of the article. To report an error, email contact@stemcelltracker.com or use our Contact page.

Independence

We don’t accept money or gifts in exchange for coverage. Any sponsored content or affiliate links are clearly labeled.

Scroll to Top